Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
about
Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer.Immune Consequences of in vitro Infection of Human Peripheral Blood Leukocytes with Vesicular Stomatitis Virus.Targeting IκappaB kinases for cancer therapy.
P2860
Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 August 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@en
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@nl
type
label
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@en
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@nl
prefLabel
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@en
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@nl
P2093
P2860
P356
P1433
P1476
Novel biomarkers of resistance ...... ic vesicular stomatitis virus.
@en
P2093
Eric Hastie
Marcela Cataldi
Megan J Moerdyk-Schauwecker
Nury Steuerwald
Sébastien A Felt
Valery Z Grdzelishvili
P2860
P304
61601-61618
P356
10.18632/ONCOTARGET.11202
P407
P577
2016-08-11T00:00:00Z